
Genelife Clinical Research Pvt. Ltd.
CDSCO-registered CRO in India offering Phase I–IV, RWE, and regulatory services
CDSCO-registered CRO in India running Phase I–IV trials, real world evidence studies, and bioequivalence (BABE) studies for pharma, biotech, and device sponsors. Offices in Mumbai, California, Cambridge, and Hamburg support multi-regional programs. Headquartered in Mumbai, India.
Phases
Indications / Therapeutic Areas
Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
Modalities
Technical specifications & accreditations
Accreditations
About this organization
Overview
Genelife Clinical Research Pvt. Ltd. is a Clinical Research Organization headquartered in Mumbai, India, founded in 2010. The company is registered with the Central Drugs Standard Control Organisation (CDSCO) under Registration No. CRO/MH/2026/000159.
Services
- Clinical operations, including site management, monitoring, and project management
- Phase I–IV clinical trials and Real World Evidence studies
- Regulatory affairs, including IND, NDA, and ANDA submissions for CDSCO, FDA, and EMA
- Pharmacovigilance, including SAE reporting, signal detection, and CTD Module II preparation
- Data management with EDC and CDISC compliance
- Biostatistics, including ICH E9-aligned analysis, SAP development, and PK/PD analysis
- Medical writing for protocols, CSRs, IBs, and DSURs
- Bioavailability/bioequivalence (BABE) study support
- Quality assurance, including GCP audits and inspection readiness
- Epidemiology and disease surveillance to support feasibility and site selection
Therapeutic and Product Focus
The company reports work across biologics (including biosimilars, recombinant peptides, vaccines, and adenoviral vector delivery systems), medical devices, small molecule drugs, and oncology, cardiology, and CNS programs. It also lists cosmeceutical and nutraceutical study support.
Global Presence
Genelife operates offices in Mumbai (India), Carson, California (USA), Cambridge (UK), and Hamburg (Germany). The company states it works with sponsors across multiple continents.
Certifications
| Authority | Identifier | Source |
|---|---|---|
| CDSCO | CRO/MH/2026/000159 | View |
Locations
Mumbai, India (Headquarters)
Mumbai · India
Carson, California
Carson · California · USA
Cambridge, UK
Cambridge · United Kingdom
Hamburg, Germany
Hamburg · Germany
Similar companies
Similar profiles by shared services, phases, and indications.
Innovate Research- Phase I Clinical Trials
- Phase II Clinical Trials
MMS Holdings- Phase I Clinical Trials
- Phase II Clinical Trials
Clario- Phase I Clinical Trials
- Phase II Clinical Trials
Fortrea- Phase I Clinical Trials
- Phase II Clinical Trials
TFS HealthScience- Phase I Clinical Trials
- Phase II Clinical Trials
Signant Health- Phase I Clinical Trials
- Phase II Clinical Trials
Accelsiors- Phase I Clinical Trials
- Phase II Clinical Trials
Velocity Clinical Research- Phase I Clinical Trials
- Phase II Clinical Trials
View all alternatives →See similar CROs ranked by shared capabilities
Submit a verified review for this organization.
Markdown mirror: /companies/genelifecr.md